# Phase 00 completion report

Phase 00, Company, Product and Quality Constitution, is complete as a documentation phase. Phase 01 has not started.

The check was `npm run constitution:phase00` on 2026-10-13. Exit code 0. 19 passed, 0 failed.

## Features

| Feature | Register status | Evidence | What remains unsigned |
| --- | --- | --- | --- |
| P00-F01 Product charter and markets | ACCEPTED | Benjamin Tetteh Nartey, product owner, approved `charter-2026.10` on 2026-10-13T13:26:00Z. The pending draft remains in `approvalHistory`. Every capability has a persona and an intended use. | No regulatory or clinical approval. |
| P00-F02 Intended-use registry | ACCEPTED | 158 feature entries. Mandatory fields are checked. Classification defaults to pending and `unregulated` is rejected. | Owner names are null. No classification is assessed. |
| P00-F03 Architecture decisions and review | ACCEPTED | `DEC-SAMPLE-001` traces to author "CuraSphere constitution record" and review state `in-review`. | Architecture, security, and clinical signatures are null. |
| P00-F04 Clinical and AI risk governance | ACCEPTED | `RISK-SAMPLE-HIGH-001` is blocked. Adding a release approval is rejected. Validation evidence is null. | No clinical validation. Model, dataset, and prompt are not selected. |
| P00-F05 Release and DoD constitution | ACCEPTED | An incomplete gate manifest is rejected. Clinical-impact without a named sign-off is rejected. Break-glass without an approver is rejected. | No clinical sign-off and no completed surveillance study. |

ACCEPTED is the feature register's completed state. It means the feature's own acceptance checks passed. It does not mean a regulator or a clinical reviewer signed.

## Source exit criteria

- No application code beyond documentation tooling. Met. Changes are under `docs/constitution` and `tools/constitution`, plus the `constitution:phase00` script.
- Every future feature has an owner, intended user, intended use, and risk class. Met by `docs/constitution/intended-use-registry.json`. The risk class is provisional and is not a validated clinical risk score.
- Architecture, security, and clinical review workflow exists. Met. The sample decision is in review. The checker refuses to mark it accepted without named signatures.

## Approvals that are not claimed

- Security and privacy approval: not recorded.
- Clinical approval: not recorded.
- Architecture approval: not recorded.
- Authorization to start Phase 01: not recorded.
- Production jurisdiction: not selected.
- Regulatory classification: pending.
- Clinical validation: none.

The source specification document is not in this checkout. The phase specification's reproduction of the Phase 00 scope was used, and that gap is recorded in ADR-0049.

Stopping here. Phase 01 needs a separate instruction.
